References and key information
Year | Author | Article/abstract | Study design; number of participants | Medication type | Intervention to improve safety | Care transition |
2011 | Avanzini et al57 | Article | Observational study; 142 | Insulin | Standardised protocol | Intensive cardiac care unit to general ward |
2011 | Nordenholz et al58 | Abstract | Cohort study; 106 | Anticoagulant | Clinical care pathway | Emergency department to primary care |
2011 | Reger et al59 | Article | Observational study; 207 | Anticoagulant | Discharge pathway | Hospital to primary care |
2011 | Schillig et al60 | Article | Randomised controlled trial; 500 | Anticoagulant | Pharmacist involvement | Hospital to primary care |
2011 | Stafford et al61 | Article | Cohort study; 268 | Anticoagulant | Pharmacist involvement | Hospital to primary care |
2012 | Falana et al62 | Abstract | Cohort study; 88 | Anticoagulant | Pharmacist involvement | Hospital to outpatient clinic |
2013 | Martin III et al63 | Article | Cohort study; not defined | High-risk medications | Pharmacist involvement | Hospital to primary care |
2014 | Falconieri et al64 | Article | Cohort study; 32 | Anticoagulant | Transfer of care programme | Emergency department to primary care |
2014 | Martins et al65 | Abstract | Randomised clinical trial; 280 | Anticoagulant | Outpatient clinic | Outpatient clinic to primary care |
2015 | Padron and Miyares66 | Article | Cohort study; 409 | Anticoagulant | Anticoagulation stewardship programme | Hospital to outpatient care |
2015 | Dunn et al67 | Article | Cohort study; 797 | Anticoagulant | Information pack | Hospital to outpatient clinic |
2015 | Quach et al68 | Abstract | Randomised controlled trial; 307 | High-risk medications | Medication reconciliation | Primary care to the emergency department |
2015 | Yilmaz et al69 | Abstract | Randomised controlled trial; protocol only | High-risk medications | Medication reconciliation and discharge counselling | Hospital to primary care |
2016 | Ha et al70 | Article | Cohort study; 109 | Anticoagulant | Standardised protocol | Hospital to primary care |
2017 | Bryant et al71 | Abstract | Retrospective observational analysis; 220 | Anticoagulant | Pharmacist involvement | Emergency department to primary care |
2017 | Castelli et al72 | Article | Randomised controlled trial; 25 | Anticoagulant | Information pack for patients | Hospital to primary care |
2017 | Chamoun et al73 | Article | Cohort study; 206 | Anticoagulant | Standardised protocol | Hospital to primary care |
2017 | Wei et al49 | Article | Randomised controlled trial; 28 | Insulin | Remote glucose monitoring | Hospital to primary care |
2017 | Zdyb et al74 | Article | Retrospective record analysis; 85 | Anticoagulant | Counselling and education | Emergency department to primary care |
2018 | Herges et al75 | Article | Retrospective record analysis; 1004 | High-risk medications | Pharmacist involvement | Hospital to primary care |
2019 | Dempsey et al76 | Abstract | Observational study; 247 | High-risk medications | Pharmacist involvement | Hospital to primary care |
2019 | Pyrlis et al77 | Article | Randomised controlled trial; 105 | Insulin | Transition diabetes team | Hospital to primary care |
2020 | Kapoor et al56 | Article | Randomised controlled trial; 162 | Anticoagulant | Pharmacist involvement | Hospital to primary care |
2020 | Liang et al78 | Article | Randomised controlled trial; 152 | Anticoagulant | Pharmacist involvement | Hospital to primary care |
2020 | Lim et al79 | Article | Retrospective case series; 120 | Anticoagulant | Outpatient clinic | Emergency department to outpatient clinic |
2020 | Tyedin et al80 | Article | Cohort study; 238 | Anticoagulant | Pharmacist involvement | Hospital to primary care |
2020 | Andre et al81 | Abstract | Observational study; 162 | Anticoagulant | Medication reconciliation | Primary care to hospital |
2022 | Bakey and Nguyen82 | Article | Cohort study; 58 | Anticoagulant | Pharmacist involvement | Emergency department to primary care |
2021 | Bawazeer et al83 | Abstract | Randomised controlled trial; 107 | High-risk medications | Medication reconciliation, counselling, follow-up | Hospital to primary care |
2021 | DeSancho et al84 | Article | Quality improvement; 409 | Anticoagulant | Counselling and education | Hospital to primary care |
2021 | Gurwitz et al85 | Article | Randomised controlled trial; 361 | High-risk medications | Pharmacist involvement | Hospital to primary care |
2021 | Kane-Gill et al48 | Article | Quality improvement; 2127 | High-risk medications | Pharmacist involvement | Primary care to nursing home |
2021 | Magny-Normilus et al86 | Article | Randomised controlled trial; 180 | Insulin | Discharge intervention | Hospital to primary care |
2021 | Zabrosky et al87 | Abstract | Quality improvement; 218 | High-risk medications | Standardised protocols for transfer of care | Hospital to primary care |
2022 | Lázaro Cebas et al88 | Article | Cohort study; 589 | High-risk medications | Pharmacist involvement | Hospital to primary care |